G
Gao Zhou
Researcher at Case Western Reserve University
Publications - 3
Citations - 353
Gao Zhou is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 227 citations. Previous affiliations of Gao Zhou include Stanford University.
Papers
More filters
Journal ArticleDOI
Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information.
Xiao Li,Jessilyn Dunn,Denis Salins,Gao Zhou,Wenyu Zhou,Sophia Miryam Schüssler-Fiorenza Rose,Sophia Miryam Schüssler-Fiorenza Rose,Dalia Perelman,Elizabeth Colbert,Ryan Runge,Shannon Rego,Ria Sonecha,Somalee Datta,Tracey McLaughlin,Michael Snyder +14 more
TL;DR: Wearable devices were useful in identification of early signs of Lyme disease and inflammatory responses and developed a personalized, activity-based normalization framework to identify abnormal physiological signals from longitudinal data for facile disease detection, and wearables distinguish physiological differences between insulin-sensitive and -resistant individuals.
Journal ArticleDOI
CTLA-4 expression by B-1a B cells is essential for immune tolerance
Yang Yang,Xiao Li,Zhihai Ma,Chunlin Wang,Qunying Yang,Miranda Byrne-Steele,Rongjian Hong,Qing Min,Gao Zhou,Yong Cheng,Guang Qin,Justin Youngyunpipatkul,James B. Wing,Shimon Sakaguchi,Christian Toonstra,Lai-Xi Wang,Jose G. Vilches-Moure,Denong Wang,Michael Snyder,Ji-Yang Wang,Ji-Yang Wang,Jian Han,Leonore A. Herzenberg +22 more
TL;DR: The authors showed that deletion of CTLA-4 from B-1a cells results in mice that spontaneously develop autoantibodies, T follicular helper (Tfh) cells and germinal centers (GCs) in the spleen, and autoimmune pathology later in life.
Journal ArticleDOI
Genetic alteration and ctDNA mutation profiling of esophageal cancer in Chinese patients.
TL;DR: Wang et al. as discussed by the authors demonstrated the utility of liquid biopsy to draw a ctDNA mutation profiling of esophageal cancer in Chinese patients and demonstrated that the most frequent mutations were found in TP53 gene, which account for 89.1% of total plasma and 90.4% of tumor tissues.